These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32608232)

  • 41. Real-Time Analysis on Drug-Antibody Ratio of Antibody-Drug Conjugates for Synthesis, Process Optimization, and Quality Control.
    Tang Y; Tang F; Yang Y; Zhao L; Zhou H; Dong J; Huang W
    Sci Rep; 2017 Aug; 7(1):7763. PubMed ID: 28798339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Affinity profiling of monoclonal antibody and antibody-drug-conjugate preparations by coupled liquid chromatography-surface plasmon resonance biosensing.
    Lakayan D; Haselberg R; Gahoual R; Somsen GW; Kool J
    Anal Bioanal Chem; 2018 Dec; 410(30):7837-7848. PubMed ID: 30328504
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design and Validation of Linkers for Site-Specific Preparation of Antibody-Drug Conjugates Carrying Multiple Drug Copies Per Cysteine Conjugation Site.
    Kumar A; Mao S; Dimasi N; Gao C
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ultrasensitive Characterization of Charge Heterogeneity of Therapeutic Monoclonal Antibodies Using Strong Cation Exchange Chromatography Coupled to Native Mass Spectrometry.
    Yan Y; Liu AP; Wang S; Daly TJ; Li N
    Anal Chem; 2018 Nov; 90(21):13013-13020. PubMed ID: 30280893
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Custom-Designed Affinity Capture LC-MS F(ab')2 Assay for Biotransformation Assessment of Site-Specific Antibody Drug Conjugates.
    Su D; Ng C; Khosraviani M; Yu SF; Cosino E; Kaur S; Xu K
    Anal Chem; 2016 Dec; 88(23):11340-11346. PubMed ID: 27779866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A rapid on-line method for mass spectrometric confirmation of a cysteine-conjugated antibody-drug-conjugate structure using multidimensional chromatography.
    Birdsall RE; Shion H; Kotch FW; Xu A; Porter TJ; Chen W
    MAbs; 2015; 7(6):1036-44. PubMed ID: 26305867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of Solid-Phase Site-Specific Conjugation and Its Application toward Generation of Dual Labeled Antibody and Fab Drug Conjugates.
    Puthenveetil S; Musto S; Loganzo F; Tumey LN; O'Donnell CJ; Graziani E
    Bioconjug Chem; 2016 Apr; 27(4):1030-9. PubMed ID: 26942771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Site-Specific Antibody-Drug Conjugation Using Microbial Transglutaminase.
    Dickgiesser S; Deweid L; Kellner R; Kolmar H; Rasche N
    Methods Mol Biol; 2019; 2012():135-149. PubMed ID: 31161507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of a charge reducing agent to enable intact mass analysis of cysteine-linked antibody-drug-conjugates by native mass spectrometry.
    Pacholarz KJ; Barran PE
    EuPA Open Proteom; 2016 Jun; 11():23-27. PubMed ID: 29900109
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multi-attribute method based characterization of antibody drug conjugates (ADC) at the intact and subunit levels.
    Martelet A; Garrigue V; Zhang Z; Genet B; Guttman A
    J Pharm Biomed Anal; 2021 Jul; 201():114094. PubMed ID: 33957368
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two-Dimensional Liquid Chromatography Coupled to High-Resolution Mass Spectrometry for the Analysis of ADCs.
    Chapel S; Rouvière F; Sarrut M; Heinisch S
    Methods Mol Biol; 2020; 2078():163-185. PubMed ID: 31643056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokinetics.
    Thompson P; Fleming R; Bezabeh B; Huang F; Mao S; Chen C; Harper J; Zhong H; Gao X; Yu XQ; Hinrichs MJ; Reed M; Kamal A; Strout P; Cho S; Woods R; Hollingsworth RE; Dixit R; Wu H; Gao C; Dimasi N
    J Control Release; 2016 Aug; 236():100-16. PubMed ID: 27327768
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advances in the Development of Site-Specific Antibody-Drug Conjugation.
    Zhou Q; Kim J
    Anticancer Agents Med Chem; 2015; 15(7):828-36. PubMed ID: 25731178
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficient Preparation of Site-Specific Antibody-Drug Conjugates Using Cysteine Insertion.
    Dimasi N; Fleming R; Zhong H; Bezabeh B; Kinneer K; Christie RJ; Fazenbaker C; Wu H; Gao C
    Mol Pharm; 2017 May; 14(5):1501-1516. PubMed ID: 28245132
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Site-specific antibody drug conjugates for cancer therapy.
    Panowski S; Bhakta S; Raab H; Polakis P; Junutula JR
    MAbs; 2014; 6(1):34-45. PubMed ID: 24423619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Site-specific antibody-drug conjugate heterogeneity characterization and heterogeneity root cause analysis.
    Cao M; De Mel N; Jiao Y; Howard J; Parthemore C; Korman S; Thompson C; Wendeler M; Liu D
    MAbs; 2019; 11(6):1064-1076. PubMed ID: 31198090
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is hydrophobic interaction chromatography the most suitable technique to characterize site-specific antibody-drug conjugates?
    D'Atri V; Pell R; Clarke A; Guillarme D; Fekete S
    J Chromatogr A; 2019 Feb; 1586():149-153. PubMed ID: 30554777
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conformation and dynamics of interchain cysteine-linked antibody-drug conjugates as revealed by hydrogen/deuterium exchange mass spectrometry.
    Pan LY; Salas-Solano O; Valliere-Douglass JF
    Anal Chem; 2014 Mar; 86(5):2657-64. PubMed ID: 24512515
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An Online Four-Dimensional HIC×SEC-IM×MS Methodology for Proof-of-Concept Characterization of Antibody Drug Conjugates.
    Ehkirch A; D'Atri V; Rouviere F; Hernandez-Alba O; Goyon A; Colas O; Sarrut M; Beck A; Guillarme D; Heinisch S; Cianferani S
    Anal Chem; 2018 Feb; 90(3):1578-1586. PubMed ID: 29260862
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conjugation site characterization of antibody-drug conjugates using electron-transfer/higher-energy collision dissociation (EThcD).
    Song Y; Gao J; Meng Q; Tang F; Wang Y; Zeng Y; Huang W; Shao H; Zhou H
    Anal Chim Acta; 2023 Apr; 1251():340978. PubMed ID: 36925279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.